Waverley Pharma (TSXV:WAVE) Price-to-Tangible-Book : (As of Jun. 13, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Price-to-Tangible-Book?

As of today (2024-06-13), Waverley Pharma's share price is C$0.02. Waverley Pharma's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was C$-0.03. Hence, Waverley Pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Waverley Pharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 8 years, Waverley Pharma's highest Price to Tangible Book Ratio was 80.00. The lowest was 2.54. And the median was 6.30.

TSXV:WAVE's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.8
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Waverley Pharma's share price is C$0.02. Waverley Pharma's Book Value per Sharefor the quarter that ended in Mar. 2024 was C$-0.03. Hence, Waverley Pharma's P/B Ratio of today is .

Waverley Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Waverley Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Price-to-Tangible-Book Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

5.56

31.25

80.00

Waverley Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Waverley Pharma's Price-to-Tangible-Book

For the Biotechnology subindustry, Waverley Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Waverley Pharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Waverley Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Waverley Pharma's Price-to-Tangible-Book falls into.

Waverley Pharma Price-to-Tangible-Book Calculation

Waverley Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.02	/	-0.031
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Waverley Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Executives

Albert David Friesen

10% Security Holder, Director, Senior Officer